The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

Alliance News Detail


DIRECTOR DEALINGS: Glaxo Vaccines President And Associate Sell Shares

[ 11 Feb 2019 16:15 ]

LONDON (Alliance News) - GlaxoSmithKline PLC on Monday said Global Vaccines President Roger Connor and a close associate sold shares on Thursday, the same day the company announced its 2018 results.

Connor sold 6,464 shares at 1,557 pence each for GBP100,645 while a close associate named as "Mrs D Connor" sold 23,205 shares at 1,554.29p each for GBP360,673. Roger Connor's beneficial interest following these transactions was not disclosed.

Pharma major Glaxo posted a pretax profit of GBP4.80 billion for 2018, up 36% from GBP3.53 billion in 2017. Revenue was GBP30.82 billion, rising from GBP30.19 billion in 2017.

Shares in Glaxo were down 1.3% at 1,545.00p each on Monday.

By Anna Farley; annafarley@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.


DIRECTOR DEALINGS: Glaxo Vaccines President And Associate Sell Shares - Alliance News

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds